2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …

PA Heidenreich, B Bozkurt, D Aguilar, LA Allen… - Journal of the American …, 2022 - jacc.org
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

European Society of Cardiology: cardiovascular disease statistics 2021

A Timmis, P Vardas, N Townsend… - European heart …, 2022 - academic.oup.com
Aims This report from the European Society of Cardiology (ESC) Atlas Project updates and
expands upon the widely cited 2019 report in presenting cardiovascular disease (CVD) …

[HTML][HTML] A placebo-controlled trial of percutaneous coronary intervention for stable angina

CA Rajkumar, MJ Foley, F Ahmed-Jushuf… - … England Journal of …, 2023 - Mass Medical Soc
Background Percutaneous coronary intervention (PCI) is frequently performed to reduce the
symptoms of stable angina. Whether PCI relieves angina more than a placebo procedure in …

2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American …

Writing Committee Members, M Gulati, PD Levy… - Journal of the American …, 2021 - jacc.org
Aim This clinical practice guideline for the evaluation and diagnosis of chest pain provides
recommendations and algorithms for clinicians to assess and diagnose chest pain in adult …

Optical coherence tomography in coronary atherosclerosis assessment and intervention

M Araki, SJ Park, HL Dauerman, S Uemura… - Nature Reviews …, 2022 - nature.com
Since optical coherence tomography (OCT) was first performed in humans two decades ago,
this imaging modality has been widely adopted in research on coronary atherosclerosis and …

Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta …

MS Sabatine, BA Bergmark, SA Murphy, PT O'Gara… - The Lancet, 2021 - thelancet.com
Background The optimal revascularisation strategy for patients with left main coronary artery
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …

[HTML][HTML] Five-year outcomes after PCI or CABG for left main coronary disease

GW Stone, AP Kappetein, JF Sabik… - … England Journal of …, 2019 - Mass Medical Soc
Background Long-term outcomes after percutaneous coronary intervention (PCI) with
contemporary drug-eluting stents, as compared with coronary-artery bypass grafting …

Five-year outcomes with PCI guided by fractional flow reserve

P Xaplanteris, S Fournier, NHJ Pijls… - … England Journal of …, 2018 - Mass Medical Soc
Background We hypothesized that fractional flow reserve (FFR)–guided percutaneous
coronary intervention (PCI) would be superior to medical therapy as initial treatment in …

Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial

R Al-Lamee, D Thompson, HM Dehbi, S Sen, K Tang… - The Lancet, 2018 - thelancet.com
Background Symptomatic relief is the primary goal of percutaneous coronary intervention
(PCI) in stable angina and is commonly observed clinically. However, there is no evidence …

Health-status outcomes with invasive or conservative care in coronary disease

JA Spertus, PG Jones, DJ Maron… - … England Journal of …, 2020 - Mass Medical Soc
Background In the ISCHEMIA trial, an invasive strategy with angiographic assessment and
revascularization did not reduce clinical events among patients with stable ischemic heart …